Reynders McVeigh Capital Management’s UnitedHealth UNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-750
| Closed | -$393K | – | 199 |
|
|
2025
Q1 | $393K | Sell |
750
-2
| -0.3% | -$1.02K | 0.02% | 148 |
|
|
2024
Q4 | $380K | Sell |
752
-60
| -7% | -$34.1K | 0.02% | 153 |
|
|
2024
Q3 | $475K | Buy |
812
+52
| +7% | +$29.4K | 0.03% | 141 |
|
|
2024
Q2 | $387K | Hold |
760
| – | – | 0.02% | 151 |
|
|
2024
Q1 | $376K | Buy |
760
+40
| +6% | +$20.3K | 0.02% | 153 |
|
|
2023
Q4 | $379K | Sell |
720
-188
| -21% | -$100K | 0.02% | 153 |
|
|
2023
Q3 | $458K | Sell |
908
-25
| -3% | -$12.3K | 0.03% | 133 |
|
|
2023
Q2 | $449K | Sell |
933
-108
| -10% | -$52.8K | 0.03% | 145 |
|
|
2023
Q1 | $492K | Sell |
1,041
-249
| -19% | -$120K | 0.03% | 133 |
|
|
2022
Q4 | $684K | Sell |
1,290
-8
| -0.6% | -$4.24K | 0.05% | 112 |
|
|
2022
Q3 | $656K | Sell |
1,298
-55
| -4% | -$28.9K | 0.05% | 115 |
|
|
2022
Q2 | $695K | Sell |
1,353
-14
| -1% | -$7.03K | 0.05% | 119 |
|
|
2022
Q1 | $697K | Sell |
1,367
-38
| -3% | -$18.3K | 0.04% | 129 |
|
|
2021
Q4 | $706K | Buy |
1,405
+1
| +0.1% | +$453 | 0.04% | 135 |
|
|
2021
Q3 | $549K | Sell |
1,404
-309
| -18% | -$128K | 0.03% | 145 |
|
|
2021
Q2 | $686K | Sell |
1,713
-153
| -8% | -$61K | 0.04% | 131 |
|
|
2021
Q1 | $694K | Sell |
1,866
-638
| -25% | -$221K | 0.05% | 131 |
|
|
2020
Q4 | $878K | Buy |
2,504
+412
| +20% | +$138K | 0.06% | 111 |
|
|
2020
Q3 | $652K | Buy |
2,092
+336
| +19% | +$103K | 0.05% | 129 |
|
|
2020
Q2 | $518K | Buy |
1,756
+187
| +12% | +$53.6K | 0.05% | 134 |
|
|
2020
Q1 | $391K | Buy |
1,569
+16
| +1% | +$4.4K | 0.04% | 132 |
|
|
2019
Q4 | $457K | Hold |
1,553
| – | – | 0.04% | 150 |
|
|
2019
Q3 | $337K | Buy |
1,553
+200
| +15% | +$48.3K | 0.04% | 174 |
|
|
2019
Q2 | $330K | Sell |
1,353
-59
| -4% | -$14.2K | 0.04% | 177 |
|
|
2019
Q1 | $349K | Sell |
1,412
-48
| -3% | -$12.2K | 0.04% | 160 |
|
|
2018
Q4 | $364K | Buy |
1,460
+105
| +8% | +$27.7K | 0.05% | 146 |
|
|
2018
Q3 | $360K | Sell |
1,355
-105
| -7% | -$27.3K | 0.04% | 160 |
|
|
2018
Q2 | $358K | Hold |
1,460
| – | – | 0.05% | 158 |
|
|
2018
Q1 | $312K | Buy |
1,460
+59
| +4% | +$13.5K | 0.04% | 168 |
|
|
2017
Q4 | $309K | Hold |
1,401
| – | – | 0.04% | 171 |
|
|
2017
Q3 | $274K | Hold |
1,401
| – | – | 0.04% | 178 |
|
|
2017
Q2 | $260K | Sell |
1,401
-145
| -9% | -$25.4K | 0.03% | 187 |
|
|
2017
Q1 | $254K | Buy |
1,546
+87
| +6% | +$14.2K | 0.03% | 194 |
|
|
2016
Q4 | $233K | Hold |
1,459
| – | – | 0.03% | 210 |
|
|
2016
Q3 | $204K | Buy |
1,459
+37
| +3% | +$5.18K | 0.03% | 210 |
|
|
2016
Q2 | $201K | Buy |
+1,422
| New | +$190K | 0.03% | 216 |
|
Other funds holding UNH
Reynders McVeigh Capital Management's UNH Position: Q2 2025 in Review
Reynders McVeigh Capital Management sold out of UnitedHealth (UNH) in Q2 2025, closing a stake of 750 shares — an estimated $393K sold.
Reynders McVeigh Capital Management first reported a position in UNH in Q2 2016 and held it in 36 quarters. The position peaked at $878K in Q4 2020. 3,177 funds tracked by Wall St. Rank hold UNH as of Q2 2025.
- Reynders McVeigh Capital Management reported no remaining UnitedHealth position as of Q2 2025 after selling out during the quarter.
- Reynders McVeigh Capital Management sold 750 UnitedHealth shares in Q2 2025, an estimated $393K.
- Reynders McVeigh Capital Management first reported a position in UnitedHealth in Q2 2016 and held it in 36 quarters.
- Reynders McVeigh Capital Management's UnitedHealth position peaked at $878K in Q4 2020.
- 3,177 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2025.
Based on Reynders McVeigh Capital Management's 13F filing for Q2 2025, filed 4 Sep 2025.